Immunometabolic Pathways Linking Obesity and Diabetes Mellitus to the Initiation of Pancreatic Ductal Adenocarcinoma

Read full text Summarise with VIRAT
Authors: Rexiati Ruze, Remila Tuerxun, Tiemin Jiang, Yingmei Shao and; Tuerganaili Aji, Tuerganaili Aji
Cited by: 0
References: 293

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Obesity and diabetes mellitus (DM), whose global prevalence has risen steeply, have emerged as major yet potentially modifiable determinants of pancreatic ductal adenocarcinoma (PDAC) risk. The long preclinical latency of PDAC, together with the chronic and systemic nature of metabolic diseases, creates an extended window during which immunometabolic perturbations are able to shape the earliest events in tumorigenesis. In individuals with obesity and DM, chronic hyperinsulinemia, hyperglycemia, dyslipidemia, adipose tissue inflammation, hormonal disturbances, and microbiome dysbiosis converge to reprogram whole-body metabolism and remodel the pancreatic niche. These changes increase nutrient and metabolite availability, activate advanced glycation end product (AGE)–receptor for AGE (RAGE) signaling, and sustain low-grade inflammation. Within the pancreas, ectopic fat deposition, stromal activation, and immune cell reeducation gradually establish a fibrotic and immunosuppressive milieu that favors the selection and expansion of Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant and other genomically altered epithelial cells. In this chapter, obesity- and DM-associated pancreatic carcinogenesis is reframed as an immunometabolic disease of PDAC initiation. We summarize how systemic metabolic derangements impinge on pancreatic epithelial, stromal, and immune compartments; how adipokines, cytokines, microbial products, and extracellular vesicles act as endocrine and paracrine mediators; and how cell-intrinsic programs such as oxidative stress, endoplasmic reticulum (ER) stress, autophagy, and epithelial–mesenchymal transition (EMT) are rewired to support premalignant progression. Finally, we discuss the implications of this integrated immunometabolic model for prevention, risk stratification, and early detection of PDAC in high-risk populations with obesity and DM, highlighting emerging biomarkers and potential therapeutic targets.

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research Cancer Lipids and Metabolism Metabolism Diabetes and Cancer

Publication details

Journal / source
IntechOpen eBooks
Publication date
25 March 2026
Language
EN
Document type
Book chapter